Home >> Life Sciences >> Healthcare

Progressive Supranuclear Palsy - Pipeline Review, H1 2017

Published: Jun-2017 | Format: PDF | Global Markets Direct | Number of pages: 75 | Code: MRS - 139817

Progressive Supranuclear Palsy - Pipeline Review, H1 2017

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Progressive Supranuclear Palsy - Pipeline Review, H1 2017, provides an overview of the Progressive Supranuclear Palsy (Central Nervous System) pipeline landscape.

Progressive supranuclear palsy, also called Steele-Richardson-Olszewski syndrome is a rare neurodegenerative disease that leads to difficulty with balance, movement, vision, speech and swallowing. Symptoms include fatigue, headaches, dizziness, depression, Parkinsonism, behavioral, cognitive, and gait disturbances that cause imbalance and arthralgias. The only proven risk factor for progressive supranuclear palsy is age. Treatment includes anticholinergic medications.  

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Progressive Supranuclear Palsy - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Progressive Supranuclear Palsy (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Progressive Supranuclear Palsy (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Progressive Supranuclear Palsy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 3, 4, 1, 2, 1 and 1 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 1 molecules, respectively.

Progressive Supranuclear Palsy (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Progressive Supranuclear Palsy (Central Nervous System).
- The pipeline guide reviews pipeline therapeutics for Progressive Supranuclear Palsy (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources. 
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Progressive Supranuclear Palsy (Central Nervous System) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Progressive Supranuclear Palsy (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects. 
- The pipeline guide reviews latest news related to pipeline therapeutics for Progressive Supranuclear Palsy (Central Nervous System)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Progressive Supranuclear Palsy (Central Nervous System).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Progressive Supranuclear Palsy (Central Nervous System) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Progressive Supranuclear Palsy - Overview
Progressive Supranuclear Palsy - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Progressive Supranuclear Palsy - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Progressive Supranuclear Palsy - Companies Involved in Therapeutics Development
AB Science SA
AbbVie Inc
AlzProtect SAS
Asceneuron SA
Bristol-Myers Squibb Company
Cortice Biosciences Inc
Intellect Neurosciences Inc
K-Stemcell Co Ltd
Merck & Co Inc
Prana Biotechnology Ltd
TauRx Therapeutics Ltd
Progressive Supranuclear Palsy - Drug Profiles
ABBV-8E12 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ASN-120290 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
AZP-2006 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
BMS-986168 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
DC-TAB - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
DPC-016 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
masitinib - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
MK-8719 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
PBT-434 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Stem Cell Therapy for Spinal Cord Injury, Alzheimer's Disease, Progressive Supranuclear Palsy and Cerebral Palsy - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
TauC-3 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
tolfenamic acid - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
TPI-287 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
TRx-0237 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Progressive Supranuclear Palsy - Dormant Projects
Progressive Supranuclear Palsy - Product Development Milestones
Featured News & Press Releases
May 04, 2017: AlzProtect : The American Food and Drug Administration (FDA) Has Granted AZP2006 the Orphan Drug Designation for the Treatment of Progressive Supranuclear Palsy (PSP)
Apr 04, 2017: Asceneuron Receives Approval for Phase I Study of Oral Tau Inhibitor
Jan 25, 2017: AbbVie Initiates Phase 2 Clinical Trial Programs for ABBV-8E12, an Investigational Anti-Tau Antibody, in Early Alzheimer's Disease and Progressive Supranuclear Palsy
Oct 13, 2016: C2N Diagnostics Completes Phase 1 Clinical Study of C2N-8E12 (ABBV-8E12) Among Individuals with Progressive Supranuclear Palsy
Jul 17, 2015: C2N And Abbvie Announce FDA Orphan Drug Designation Of C2N-8E12 (ABBV-8E12) For The Treatment Of Progressive Supranuclear Palsy
Jul 07, 2014: Cortice Announces Enrollment of a Phase 1 Clinical Trial Evaluating TPI 287 in Rare Tauopathy Diseases
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

                        
            

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields


Related Reports

Global Cancer Biological Therapy Analysis & Forecast 2016 To 2023

Jul-2017 | Market Research Future | Pages : 110 | Code : MRS-156473 | 4450

Introduction Biological therapy treatment is done with the help of living organisms, parts of living organisms or laboratory manufactured version of such content. There are various types of biological therapies, which inhibit specific molecules involved in development and growth of cancer tumor. Such therapies known as; cancer targeted therapies. The global cancer biological therapy market is expected to reach USD 82,276.8 million by 2023 at a C Read more

Global Articaine Hydrochloride Market Analysis & Forecast 2016 To 2021

Jun-2017 | Market Research Future | Pages : 156 | Code : MRS-156471 | 4450

Introduction Articaine is a form of an amide local anesthetic that is most commonly used in dentistry. The chemical name for articaine hydrochloride is 2-Thiophenecarboxylic acid-4-methyl-3- ((1-oxo-2-(propyl amino) propyl) amino)-methyl ester hydrochloride (C13H21ClN2O3S). The CAS Number is 23964-57-0. It is a white or almost white crystalline powder with the molecular weight of 320.84 g/mol. This drug is originally known as carticaine. It has different Read more

Global Antigen Skin Test Sales Market Report 2017

Aug-2017 | QY Research | Pages : 100 | Code : MRS-156393 | 4000

In this report, the global Antigen Skin Test market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Antigen Skin Test for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Jap Read more

2017 Global and Regional Diphenylamine (PDA) Market Research Report Forecasts 2022

May-2017 | Tuoda Research | Pages : 162 | Code : MRS-155976 | 2800

This report focus on Global and regional market, providing information on major players like manufacturers, suppliers, distributors, traders, customers, investors and etc., major types, major applications from Global and major regions such as Europe, North American, South American, Asia (Excluding China), China and etc. Data type include capacity, production, market share, price, revenue, cost, gross, gross margin, growth rate, consumption, import, export and etc. Industry chain, manufactur Read more

2017 Global and Regional Diagnostic Reagent Market Research Report Forecasts 2022

May-2017 | Tuoda Research | Pages : 169 | Code : MRS-155975 | 2800

This report focus on Global and regional market, providing information on major players like manufacturers, suppliers, distributors, traders, customers, investors and etc., major types, major applications from Global and major regions such as Europe, North American, South American, Asia (Excluding China), China and etc. Data type include capacity, production, market share, price, revenue, cost, gross, gross margin, growth rate, consumption, import, export and etc. Industry chain, manufactur Read more

2017 Global and Regional Astaxanthin Market Research Report Forecasts 2022

May-2017 | Tuoda Research | Pages : 153 | Code : MRS-155954 | 2800

This report focus on Global and regional market, providing information on major players like manufacturers, suppliers, distributors, traders, customers, investors and etc., major types, major applications from Global and major regions such as Europe, North American, South American, Asia (Excluding China), China and etc. Data type include capacity, production, market share, price, revenue, cost, gross, gross margin, growth rate, consumption, import, export and etc. Industry chain, manufactur Read more

2017 Global and Regional Microalgae Market Research Report Forecasts 2022

May-2017 | Tuoda Research | Pages : 182 | Code : MRS-155920 | 2800

This report focus on Global and regional market, providing information on major players like manufacturers, suppliers, distributors, traders, customers, investors and etc., major types, major applications from Global and major regions such as Europe, North American, South American, Asia (Excluding China), China and etc. Data type include capacity, production, market share, price, revenue, cost, gross, gross margin, growth rate, consumption, import, export and etc. Industry chain, manufactur Read more

2017 Global and Regional Eye Wash Station Market Research Report Forecasts 2022

May-2017 | Tuoda Research | Pages : 170 | Code : MRS-155885 | 2800

This report focus on Global and regional market, providing information on major players like manufacturers, suppliers, distributors, traders, customers, investors and etc., major types, major applications from Global and major regions such as Europe, North American, South American, Asia (Excluding China), China and etc. Data type include capacity, production, market share, price, revenue, cost, gross, gross margin, growth rate, consumption, import, export and etc. Industry chain, manufactur Read more

2017 Global and Regional Breast Localization Wire Market Research Report Forecasts 2022

May-2017 | Tuoda Research | Pages : 128 | Code : MRS-155867 | 2800

This report focus on Global and regional market, providing information on major players like manufacturers, suppliers, distributors, traders, customers, investors and etc., major types, major applications from Global and major regions such as Europe, North American, South American, Asia (Excluding China), China and etc. Data type include capacity, production, market share, price, revenue, cost, gross, gross margin, growth rate, consumption, import, export and etc. Industry chain, manufactur Read more

2017 Global and Regional Breast Implants Market Research Report Forecasts 2022

May-2017 | Tuoda Research | Pages : 132 | Code : MRS-155866 | 2800

This report focus on Global and regional market, providing information on major players like manufacturers, suppliers, distributors, traders, customers, investors and etc., major types, major applications from Global and major regions such as Europe, North American, South American, Asia (Excluding China), China and etc. Data type include capacity, production, market share, price, revenue, cost, gross, gross margin, growth rate, consumption, import, export and etc. Industry chain, manufactur Read more

Single User | $(USD)2000 View Pricing